Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte colony-stimulating factor reverses septic shock-induced polymorphonuclear leukocyte dysfunction

H H Simms1, R D'Amico

  • 1Department of Surgery, Brown University School of Medicine-Rhode Island Hospital, Providence 02903.

Surgery
|January 1, 1994
PubMed
Summary

Septic shock significantly reduces CD64 (Fc gamma RI) expression on polymorphonuclear leukocytes (PMNs). Granulocyte colony-stimulating factor can restore CD64 function, improving PMN oxidative metabolism and degranulation in patients with septic shock.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.

ESMO open·2025
Same author

Corrigendum to [Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo] [PHYMED: 2019 Feb 15;54:27-42 Epub 2018 Sep 19].

Phytomedicine : international journal of phytotherapy and phytopharmacology·2023
Same author

Impact of sarcopenia in SARS-CoV-2 patients during two different epidemic waves.

Clinical nutrition ESPEN·2022
Same author

Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Serial cervical-length measurements after first episode of threatened preterm labor improve prediction of spontaneous delivery prior to 37 weeks' gestation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device).

BMC pulmonary medicine·2019

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Polymorphonuclear leukocyte (PMN) function relies on Fc gamma receptor expression.
  • Fibronectin and laminin modulate CD32 (Fc gamma RII) and CD16 (Fc gamma RIII) but their effect on CD64 (Fc gamma RI) was unclear.

Purpose of the Study:

  • To define the role of CD64 (Fc gamma RI) in modulating PMN oxidative metabolism and degranulation.
  • To investigate the effects of fibronectin and laminin on CD64 expression and function in PMNs.

Main Methods:

  • PMNs from healthy volunteers and patients (controls and septic shock) were analyzed.
  • CD64 expression was measured after adherence to fibronectin or laminin.
  • Oxidative metabolism and degranulation were assessed via superoxide anion, hypochlorous acid, and N-acetyl-beta-glucosaminidase production.

Related Experiment Videos

  • Cytokines were tested for their ability to restore CD64 activity in septic shock patients.
  • Main Results:

    • Fibronectin and laminin increased CD64 expression and activity in PMNs from healthy volunteers and control patients.
    • Septic shock patients showed depressed CD64 expression and activity.
    • Granulocyte colony-stimulating factor restored both CD64 expression and biological activity in septic shock PMNs.

    Conclusions:

    • Septic shock impairs CD64 expression on PMNs.
    • Granulocyte colony-stimulating factor can restore CD64 number and function, enhancing PMN oxidative metabolism and degranulation in the context of fibronectin or laminin.
    • This suggests a potential therapeutic target for sepsis-related immune dysfunction.